Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese Hospitals

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 4022-4028

  Wang, Hui ^a   Guo, Ping ^a   Sun, Hongli ^a   Wang, He ^a   Yang, Qiwen ^a   Chen, Minjun ^a   Xu, Yingchun ^a   Zhu, Yuanjue ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CARBAPENEM; CHLORAMPHENICOL; COLISTIN; IMIPENEM; METALLO BETA LACTAMASE; RIFAMPICIN; RNA;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BLA OXA 23 GENE; BLA OXA 51 GENE; BLA OXA 66 GENE; CHINESE; GENE AMPLIFICATION; GENE ISOLATION; GENE SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL; INTEGRON; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TEACHING HOSPITAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; BLOTTING, SOUTHERN; CARBAPENEMS; CHINA; CHLORAMPHENICOL; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HOSPITALS; HUMANS; IMIPENEM; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RIFAMPIN; SEQUENCE ANALYSIS, DNA;

EID: 35848934391     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01259-06     Document Type: Article

References (30)

1. Afzal-shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
2. Brown, S., H. K. Young, and S. G. B. Amyes. 2005. Characterization of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11:15-23.
3. Brown, S., and S. Amyes. 2006. OXA-β-lactamases in Acinetobacter: the story so far. J. Antimicrob. Chemother. 57:1-3.
4. Cao, V., T. Lambert, D. Q. Nhu, H. K. Loan, N. K. Hoang, G. Arlet, and P. Courvalin. 2002. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterbacteriaceae in Vietnam. Antimicrob. Agents Chemother. 46:3739-3743.
5. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Coelho, J., N. Woodford, J. Turton, and D. M. Livermore. 2004. Multiresistant acinetobacter in the UK: how big a threat? J. Hosp. Infect. 58:167-169.
8. Coelho, J., N. Woodford, M. Afzal-Shah, and D. M. Livermore. 2006. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50:756-758.
9. Dalla-Costa, L. M., J. M. Coelho, H. A. P. H. M. Souza, M. E. S. Castro, C. J. N. Stier, K. L. Bragagnolo, A. Rea-Neto, S. R. Penteado-Filho, D. M. Livermore, and N. Woodford. 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41:3403-3406.
10. Dijkshoorn, L., B. van Harsselaar, I. Tjernberg, P. J. M. Bouvet, and M. Vaneechoutte. 1998. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst. Appl. Microbiol. 21:33-39.
11. Héritier, C., L. Poirel, P. Fournier, J. Claverie, D. Raoult, and P. Nordmann. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:4174-4179.
12. Héritier, C., L. Poirel, T. Lambert, and P. Nordmann. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202.
13. Jeon, B., S. H. Jeong, I. K. Bae, S. B. Kwon, K. Lee, D. Young, J. H. Lee, J. S. Song, and S. H. Lee. 2005. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J. Clin. Microbiol. 43:2241-2245.
14. Landman, D., J. M. Quale, D. Mayorga, A. Adedeji, K. Vangala, J. Ravishankar. C. Flores, and S. Brooks. 2002. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY.: the preantibiotic era has returned. Arch. Intern. Med. 162: 1515-1520.
15. Lévesque, C., L. Piché, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
16. Naas, T., M. Levy, C. Hirschauer, H. Marchandin, and P. Nordmann. 2005. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J. Clin. Microbiol. 43:4826-4829.
17. Nordmann, P., and T. Naas. 1994. Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with class A β-lactamases. Antimicrob. Agents Chemother. 38:104-114.
18. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
19. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
20. Tsakris, A., S. Pournaras, N. Woodford, M. I. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
21. Turton, J. F., M. E. Ward, N. Woodford, M. E. Kaufmann, R. Pike, D. M. Livermore, and T. L. Pitt. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77.
22. OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
23. Vahaboglu, H., F. Budak, M. Kasap, G. Gacar, S. Torol, A. Karadenizli, F. Kolayli, and C. Eroglu. 2006. High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centers. J. Antimicrob. Chemother. 58:537-542.
24. Vahaboglu, H., R. Ozturk, G. Aygun, F. Coskunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkun. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41:2265-2269.
25. Wang, H., and M. Chen. 2005. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn. Microbiol. Infect. Dis. 51:201-208.
26. Wang, H., M. Chen, Y. Ni, D. Chen, Z. Sun, Y. Chen, W. Zhao, X. Zou, Y. Yu, Z. Hu, X. Huang, Y. Xu, X. Xie, Y. Chu, Q. Wang, Y. Mei, B. Tian, P. Zhang, Q. Kong, X. Yu, and Y. Pan. 2005. Antimicrobial resistance analysis among nosocomial gram-negative bacilli from 10 teaching hospitals in China. Chin. J. Lab. Med. 28:1295-1303.
27. Wang, H., S. Kelkar, W. Wu, M. Chen, and J. P. Quinn. 2003. Clinical isolates of Enterbacteriaceae producing extended-spectrum β-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob. Agents Chemother. 47:790-793.
28. Woodford, N., M. J. Ellington, J. M. Coelho, J. F. Turton, M. E. Ward, S. Brown, S. G. B. Amyes, and D. M. Livermore. 2006. Multiplex PCR for gene encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.
29. Yong, D., J. H. Shin, S. Kim, Y. Lim, J. H. Yum, K. Lee, Y. Chong, and A. Bauernfeind. 2003. High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea. Antimicrob. Agents Chemother. 47:1749-1751.
30. Zarrilli, R., M. Crispino, M. Bagattini, E. Barretta, A. D. Popolo, M. Triassi, and P. Villari. 2004. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J. Clin. Microbiol. 42:946-953.